Ubiquinone Derivative Nootropic Drug Idebenone CAS 58186-27-9

Basic Info

Model No.: 58186-27-9

Function: Nutritional Therapeutics

Grade Standard: Medicine Grade

State: Solid

Volatile: Not Volatile

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

We are professional manufacture, supplier and exporter of the high purity Idebenone CAS 58186-27-9.  Idebenone CAS NO 58186-27-9 is yellow-orange crystalline solid with the molecular formula of C19H30O5 and formula weight of 338.44. Idebenone 58186-27-9 has many function, such as Idebenone can be used as an antioxidant and neuroprotective agent; protects mitochondrial membranes against lipid peroxidation and blocks glutamate neurotoxicity in vitro and in vivo and so on. Customers can take used of this excellent quality Idebenone as per their requirement.

Thera. Category: Anti nootropic

Cas No.: 58186-27-9

Synonym : 4-dione,5,6-dimethoxy-2-(10-hydroxydecyl)-3-methyl-5-cyclohexadiene-1;6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone;IDEBENONE;cv 2619;2-(10-HYDROXY-DECYL)-5,6-DIMETHOXY-3-METHYL-[1,4]BENZOQUINONE;2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione;idebonone;Idebenone98.5%Min

Molecular Weight: 338.44

Molecular formula: C19H30O5

Assay: ≥98.%

Appearance: Yellow-Orange Crystalline Solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Usage: Idebenone 58186-27-9 was initially developed for the treatment of Alzheimer's disease and other cognitive defects.(Japan)has started to investigate it for the treatment of neuromuscular diseases. (Swiss) which is well absorbed from the gut but undergoes excessive first pass metabolism in the liver, so that less than 1% reach the circulation. This rate can be improved with special formulations (suspensions) of idebenone and by administering it together with fat food; but even taking these measures bioavailability still seems to be considerably less than 14% in humans. More than 99% of the circulating drug are bound to plasma proteins. Idebenone metabolites include glucuronides and sulfates, which are mainly (~80%) excreted via the urine.